Literature DB >> 7637586

Calbindin D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: comparison between control and Alzheimer disease subjects.

K A Maguire-Zeiss1, Z W Li, L M Shimoda, R W Hamill.   

Abstract

To further investigate the role of calbindin D28k in Alzheimer's disease (AD); hippocampus, superior temporal gyrus and cerebellum from control and AD cases were examined by quantitative in situ hybridization. We report here a decrease in CaBD28k mRNA in the CA2 region of AD hippocampus compared to control subjects. There were no significant differences between AD and control subjects in the other regions studied.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7637586     DOI： 10.1016/0169-328x(95)00035-q

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN： 0169-328X


  5 in total

1.  Hippocampal calbindin-1 immunoreactivity correlate of recognition memory performance in aged mice.

Authors:  Virawudh Soontornniyomkij; Victoria B Risbrough; Jared W Young; Benchawanna Soontornniyomkij; Dilip V Jeste; Cristian L Achim
Journal:  Neurosci Lett       Date:  2012-04-06       Impact factor: 3.046

2.  Age-related downregulation of the CaV3.1 T-type calcium channel as a mediator of amyloid beta production.

Authors:  Rachel A Rice; Nicole C Berchtold; Carl W Cotman; Kim N Green
Journal:  Neurobiol Aging       Date:  2013-10-30       Impact factor: 4.673

3.  Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease.

Authors:  Allison Bradbury; Jessica Bagel; Maureen Sampson; Nicole Farhat; Wenge Ding; Gary Swain; Maria Prociuk; Patricia O'Donnell; Kenneth Drobatz; Brittney Gurda; Christopher Wassif; Alan Remaley; Forbes Porter; Charles Vite
Journal:  J Pharmacol Exp Ther       Date:  2016-06-15       Impact factor: 4.402

4.  Alzheimer's-like signaling in brains of COVID-19 patients.

Authors:  Steve Reiken; Leah Sittenfeld; Haikel Dridi; Yang Liu; Xiaoping Liu; Andrew R Marks
Journal:  Alzheimers Dement       Date:  2022-02-03       Impact factor: 21.566

5.  Calbindin Deficits May Underlie Dissociable Effects of 5-HT6 and mGlu7 Antagonists on Glutamate and Cognition in a Dual-Hit Neurodevelopmental Model for Schizophrenia.

Authors:  Sinead E Shortall; Angus M Brown; Eliot Newton-Mann; Erin Dawe-Lane; Chanelle Evans; Maxine Fowler; Madeleine V King
Journal:  Mol Neurobiol       Date:  2020-06-12       Impact factor: 5.682
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.